Quinlan Paul T sold ORKA
August 14, 2026 · Form 4 insider transaction
Quinlan Paul T sold 9,193 shares of Oruka Therapeutics, Inc. at $110.00 per share, a transaction worth $1.01M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
9,193
Price
$110.00
Total value
$1.01M
InsiderQuinlan Paul T
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 14, 2026
Filing dateAugust 14, 2026
Shares owned after34,881
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.58 to $110.55, inclusive.